Contact:
Phone: 773.880.4757
Fax: 773.880.3208
e-mail: ryogev@childrensmemorial.org

Academic Appointment:
Susan B. DePree Founders’ Board Professor in Pediatric Infectious Diseases
Northwestern University’s Feinberg School of Medicine
Deputy Director, Research-Clinical Sciences
Director, Clinical and Translational Research Program
Children’s Memorial Research Center

Clinical Appointment:
Director, Section of Pediatric, Adolescent and Maternal HIV Infection
Attending Physician
Division of Infectious Diseases
Children’s Memorial Hospital

Clinical Interests:
AIDS, AIDS/HIV Transmission and Medication Research/Treatment, HIV Testing of Pregnant Women/Policy Issues, Meningitis, Central Nervous System (CNS) Infections, Shunt Infections, Influenza, Respiratory Syncytial Virus (RSV), Human Papillomavirus

Research Interest:
Dr. Yogev’s research focuses on many NIH-sponsored clinical trials that focus on different treatment aspects of individuals affected by HIV, and his laboratory is based at Children’s Memorial Hospital. Some of the current ongoing research includes: investigating the response to routine vaccination in patients with HIV; designing potent and easily managed treatment regimens to increase adherence; modulating treatment regimens and dietary needs to facilitate normal cognitive (mental) and physiological (body weight and size) growth; and developing rapid testing for resource-limited countries. In addition, Dr. Yogev participates in multiple clinical research studies evaluating new vaccines and phase pediatric drugs (Phase 1/II).

Publications (most recent):
Arguedas A, Cespedes J, Botet FA, et al: Safety and Tolerability of Ertapenem Versus Ceftriaxone in a Double-Blind Study Performed in Children with Complicated Urinary Tract Infection, Community-Acquired Pneumonia or Skin and Soft-Tissue Infection. Intl J of Antimicrob Agents 2009; 33:163-167.

King JR, Acosta EP, Yogev R, et al: Steady-State Pharmacokinetics of Lopinavir/Ritonavir in Combination with Efavirenz in HIV-Infected Pediatric Patients. Pediatr Infect Dis J 2009; 28:159-161.

Chadwick E, Pinto JA, Yogev R, et al: Early Initiation of Lopinavir/Ritonavir in Infants Less than 6 weeks of Age: Pharmacokinetics and 24 Week Safety and Efficacy. Pediatr Infect Dis J 2009; 28: 215-219.

Saez-Llorens X, Yogev R, Arguedas A, et al: Pharmacokinetics and Safety of Famciclovir in Children with Herpes Simplex or Varicella Zoster Virus Infections. Antimicrob Agent and Chemother 2009; 53:1912-1920.

Block SL, Yogev R, Hayden FG, et al: Shedding and Immunogenicity of Live Attenuated Influenza Vaccine Virus in Subjects 5-49 Years of Age. Vaccine 2008; 26:4940-4946.

For more publications, click here.